| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1024879 | F | Inhibition of Vaccinia virus DNA synthesis in by rapid plate assay | Vaccinia virus | 93 | ALA1140145 | organism-based format | Scientific Literature | |
| 2. | ALA1024886 | F | Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as reduction in plaque formation up to 200 uM after 20 hrs | Vaccinia virus | 19 | ALA1140145 | organism-based format | Scientific Literature | |
| 3. | ALA1024887 | F | Antiviral activity against Vaccinia virus WR in BSC1 cells assessed as protection from virus-induced lysis of cell monolayer up to 200 uM after 20 hrs | Vaccinia virus | 19 | ALA1140145 | organism-based format | Scientific Literature | |
| 4. | ALA1024888 | A | Cytotoxicity against african green monkey BSC1 cells up to 200 uM after 20 to 120 hrs WST-1 based assay | Chlorocebus aethiops | 19 | ALA1140145 | cell-based format | Scientific Literature | |
| 5. | ALA1040691 | F | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | ALA1156829 | organism-based format | Novartis Malaria Screening | |
| 6. | ALA1040692 | F | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | Plasmodium falciparum | 5,614 | ALA1156829 | organism-based format | Novartis Malaria Screening | |
| 7. | ALA1040693 | T | NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7) | Homo sapiens | 5,614 | ALA1156829 | cell-based format | Novartis Malaria Screening | |
| 8. | ALA1040694 | F | NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested. | 5,614 | ALA1156829 | assay format | Novartis Malaria Screening | ||
| 9. | ALA730079 | F | ST_JUDE: Plasmodium falciparum 3D7 EC50 (uM) as measured by SYBR green dye | Plasmodium falciparum | 1,524 | ALA1154198 | organism-based format | St Jude Malaria Screening | |
| 10. | ALA730080 | F | ST_JUDE: Plasmodium falciparum K1 EC50 (uM) as measured by SYBR green dye | Plasmodium falciparum | 1,524 | ALA1154198 | organism-based format | St Jude Malaria Screening | |
| 11. | ALA1614183 | F | PUBCHEM_BIOASSAY: High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv. (Class of assay: confirmatory) | 2,044 | ALA1201862 | assay format | PubChem BioAssays | ||
| 12. | ALA1614307 | F | PUBCHEM_BIOASSAY: Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of Trypanosoma cruzi Replication. (Class of assay: confirmatory) [Related pubchem assays: 1885, 1968 ] | 4,058 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 13. | ALA1614317 | F | PUBCHEM_BIOASSAY: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis. (Class of assay: confirmatory) | 1,237 | ALA1201862 | assay format | PubChem BioAssays | ||
| 14. | ALA1614453 | F | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. (Class of assay: confirmatory) [Related pubchem assays: 1885, 1968 ] | 4,024 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 15. | ALA1614266 | F | PUBCHEM_BIOASSAY: A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol. (Class of assay: confirmatory) | 1,732 | ALA1201862 | assay format | PubChem BioAssays | ||
| 16. | ALA1614410 | F | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | Homo sapiens | 17,175 | ALA1201862 | assay format | PubChem BioAssays | |
| 17. | ALA1613829 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))] | Homo sapiens | 4,515 | ALA1201862 | assay format | PubChem BioAssays | |
| 18. | ALA1613914 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | Homo sapiens | 39,332 | ALA1201862 | assay format | PubChem BioAssays | |
| 19. | ALA1614079 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | Homo sapiens | 22,998 | ALA1201862 | assay format | PubChem BioAssays | |
| 20. | ALA1614087 | F | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | Mus musculus | 51,950 | ALA1201862 | assay format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!